SC

Subhash Chandra Srivastava

Active Director Director DIN 09396138
DIN 09396138 First appointment Nov 2021 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Subhash Chandra Srivastava

Data last updated:

Subhash Chandra Srivastava is a Director at Neuratex Pharmaceuticals Private Limited (since 2021). The company operates in Food And Beverages.

DIN 09396138
Primary Designation Director
Industry Food And Beverages
First Appointment 11 Nov 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Nov 20212021Active

Board colleagues of Subhash Chandra Srivastava

NameDINCompanyDesignation
Aruna Srivastava09396139Neuratex Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Neuratex Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Subhash Chandra Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subhash Chandra Srivastava

Subhash Chandra Srivastava currently holds 1 directorship: Neuratex Pharmaceuticals Private Limited (Director, since 11 Nov 2021).

Subhash Chandra Srivastava was first appointed on 11 Nov 2021 as Director at Neuratex Pharmaceuticals Private Limited.

The current boards of Subhash Chandra Srivastava's companies include Aruna Srivastava (Neuratex Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available